CO6831987A2 - Composición farmacéutica para uso de inflamación y dolor - Google Patents
Composición farmacéutica para uso de inflamación y dolorInfo
- Publication number
- CO6831987A2 CO6831987A2 CO13297886A CO13297886A CO6831987A2 CO 6831987 A2 CO6831987 A2 CO 6831987A2 CO 13297886 A CO13297886 A CO 13297886A CO 13297886 A CO13297886 A CO 13297886A CO 6831987 A2 CO6831987 A2 CO 6831987A2
- Authority
- CO
- Colombia
- Prior art keywords
- inflammation
- pain
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2011006758A MX357376B (es) | 2011-06-22 | 2011-06-22 | Composicion farmaceutica para uso en inflamacion y dolor. |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6831987A2 true CO6831987A2 (es) | 2014-01-10 |
Family
ID=47422093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO13297886A CO6831987A2 (es) | 2011-06-22 | 2013-12-20 | Composición farmacéutica para uso de inflamación y dolor |
Country Status (13)
Country | Link |
---|---|
AR (1) | AR086733A1 (es) |
BR (1) | BR112013033007A2 (es) |
CL (1) | CL2013003671A1 (es) |
CO (1) | CO6831987A2 (es) |
CR (1) | CR20130687A (es) |
DO (1) | DOP2013000309A (es) |
ES (1) | ES2441917B1 (es) |
GT (1) | GT201300318A (es) |
MX (1) | MX357376B (es) |
NI (1) | NI201300142A (es) |
PE (1) | PE20141530A1 (es) |
RU (1) | RU2604149C2 (es) |
WO (1) | WO2012176155A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3025717B1 (en) * | 2013-05-27 | 2018-11-07 | Farmacéuticos Rayere, S.A. | Synergistic pharmaceutical composition of two analgesics having a distinct pharmacokinetic profile |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1196307B (it) * | 1984-10-22 | 1988-11-16 | Chiesi Farma Spa | Formulazioni farmaceutiche acquose di piroxicam monoidrato |
US5091182A (en) * | 1990-07-23 | 1992-02-25 | Syntex (U.S.A.) Inc. | Dispensing units for ketorolac topical gel formlations |
US5436241A (en) * | 1994-01-14 | 1995-07-25 | Bristol-Myers Squibb Company | Topical anti-inflammatory compositions containing piroxicam |
MXPA02010828A (es) * | 2002-11-04 | 2004-07-16 | Leopoldo Espinosa Abdala | Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
RU2237470C1 (ru) * | 2003-01-27 | 2004-10-10 | Купсин Евгений Вениаминович | Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты) |
US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
MXPA04009698A (es) * | 2004-10-04 | 2006-04-05 | Maria Elena Garcia Armenta | Formulaciones farmaceuticas solidas conteniendo diacereina y meloxicam. |
WO2007148950A1 (es) * | 2006-06-20 | 2007-12-27 | Farmacéuticos Rayere, S.A. | Composición farmacéutica sinergística de ketorolaco y clonixinato de lisina |
MX2007003948A (es) * | 2007-04-02 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
-
2011
- 2011-06-22 MX MX2011006758A patent/MX357376B/es active IP Right Grant
-
2012
- 2012-06-21 RU RU2013157013/15A patent/RU2604149C2/ru active
- 2012-06-21 BR BR112013033007A patent/BR112013033007A2/pt not_active Application Discontinuation
- 2012-06-21 ES ES201390103A patent/ES2441917B1/es active Active
- 2012-06-21 WO PCT/IB2012/053157 patent/WO2012176155A1/es active Application Filing
- 2012-06-21 PE PE2013002871A patent/PE20141530A1/es not_active Application Discontinuation
- 2012-06-22 AR ARP120102254A patent/AR086733A1/es not_active Application Discontinuation
-
2013
- 2013-12-20 GT GT201300318A patent/GT201300318A/es unknown
- 2013-12-20 CL CL2013003671A patent/CL2013003671A1/es unknown
- 2013-12-20 CO CO13297886A patent/CO6831987A2/es unknown
- 2013-12-20 DO DO2013000309A patent/DOP2013000309A/es unknown
- 2013-12-20 NI NI201300142A patent/NI201300142A/es unknown
- 2013-12-20 CR CR20130687A patent/CR20130687A/es unknown
Also Published As
Publication number | Publication date |
---|---|
CR20130687A (es) | 2014-02-21 |
ES2441917A2 (es) | 2014-02-06 |
ES2441917B1 (es) | 2014-11-25 |
RU2604149C2 (ru) | 2016-12-10 |
DOP2013000309A (es) | 2014-04-15 |
NI201300142A (es) | 2015-02-25 |
BR112013033007A2 (pt) | 2017-01-31 |
PE20141530A1 (es) | 2014-11-12 |
GT201300318A (es) | 2015-05-21 |
CL2013003671A1 (es) | 2014-07-11 |
AR086733A1 (es) | 2014-01-15 |
MX357376B (es) | 2018-07-06 |
RU2013157013A (ru) | 2015-07-27 |
ES2441917R1 (es) | 2014-02-19 |
WO2012176155A1 (es) | 2012-12-27 |
MX2011006758A (es) | 2013-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR20150380A (es) | Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico | |
CO6870033A2 (es) | Compuestos terapéuticos y métodos de uso relacionados | |
CO6862148A2 (es) | Composiciones transdérmicas de ibuprofeno y métodos de uso de las mismas | |
BR112013018877A2 (pt) | composições farmacêuticas que compreendem anticorpos humanos para pcsk9 | |
CO7020907A2 (es) | Inhibidores de quinurenina-3-monooxigenasa, composiciones farmacéuticas y métodos de uso de los mismos | |
CO6801774A2 (es) | Compuestos de benzotiazol y su uso farmacéutico | |
CO7030962A2 (es) | Compuestos terapéuticamente activos y sus métodos de uso | |
CO7010834A2 (es) | Compuestos terapéuticamente activos y sus métodos de uso | |
BR112012013148A2 (pt) | formulação farmacêutica e uso | |
BR112014003802A2 (pt) | composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento | |
BR112013011448A2 (pt) | composto, composição farnmacêutica, e, uso do composto | |
BR112013017752A8 (pt) | uso de um antagonista do vegf e formulação farmacêutica | |
BR112014013760A2 (pt) | composto, composição farmacêutica e uso de um composto | |
BR112013026410A2 (pt) | compostos antimicrobianos e métodos de preparação e uso dos mesmos | |
BR112013033072A2 (pt) | agente para indução de apoptose e composição farmacêutica | |
BR112014001991A2 (pt) | certos inibidores de quinurenina-3-monooxigenase, composições farmacêuticas e métodos de uso dos mesmos | |
BR112014005669A2 (pt) | composto, composição farmacêutica e uso de um composto | |
CO6811867A2 (es) | Cannabinoides para uso en el tratamiento del dolor neuropático | |
BR112013030302A2 (pt) | composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo | |
BR112014003567A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
BR112012001797A2 (pt) | composto bicíclico e uso do mesmo para propósitos médicos | |
CO6890098A2 (es) | Compuesto pirazol y su uso farmaceutico | |
BR112014010739A2 (pt) | agentes terapêuticos e uso dos mesmos | |
CO6970609A2 (es) | Composición farmacéutica y métodos de uso de derivados de 4-pregenen-11ß-17-21-triol-3,20-diona | |
BR112013011845A2 (pt) | produto para cuidado oral e métodos de uso e fabricação do mesmo |